Machine Learning in Chemistry about 2199-44-2

Here is a brief introduction to this compound(2199-44-2)Reference of Ethyl 3,5-Dimethyl-2-pyrrolecarboxylate, if you want to know about other compounds related to this compound(2199-44-2), you can read my other articles.

Staples, Oliver D.; Hollick, Jonathan J.; Campbell, Johanna; Higgins, Maureen; McCarthy, Anna R.; Appleyard, Virginia; Murray, Karen E.; Baker, Lee; Thompson, Alastair; Ronseaux, Sebastien; Slawin, Alexandra M. Z.; Lane, David P.; Westwood, Nicholas J.; Lain, Sonia published the article 《Characterization, chemical optimization and anti-tumor activity of a tubulin poison identified by a p53-based phenotypic screen》. Keywords: JJ781 derivative antitumor design preparation structure activity p53 tubulin.They researched the compound: Ethyl 3,5-Dimethyl-2-pyrrolecarboxylate( cas:2199-44-2 ).Reference of Ethyl 3,5-Dimethyl-2-pyrrolecarboxylate. Aromatic heterocyclic compounds can be divided into two categories: single heterocyclic and fused heterocyclic. In addition, there is a lot of other information about this compound (cas:2199-44-2) here.

A robust p53 cell-based assay that exploits p53’s function as a transcription factor was used to screen a small mol. library and identify bioactive small mols. with potential antitumor activity. Unexpectedly, the majority of the highest ranking hit compounds from this screen arrest cells in mitosis and most of them impair polymerization of tubulin in cells and in vitro. One of these novel compounds, JJ78:1, was subjected to structure-activity relationship studies and optimized leading to the identification of JJ78:12. This mol. is significantly more potent than the original hit JJ78:1, as it is active in cells at two-digit nanomolar concentrations and shows clear antitumor activity in a mouse xenograft model as a single agent. The effects of nocodazole, a well established tubulin poison, and JJ78:12 on p53 levels are remarkably similar, supporting that tubulin depolymerization is the main mechanism by which JJ78:12 treatment leads to p53 activation in cells. In summary, these results identify JJ78:12 as a potential cancer therapeutic, demonstrate that screening for activators of p53 in a cell-based assay is an effective way to identify inhibitors of mitosis progression and highlights p53’s sensitivity to alterations during mitosis.

Here is a brief introduction to this compound(2199-44-2)Reference of Ethyl 3,5-Dimethyl-2-pyrrolecarboxylate, if you want to know about other compounds related to this compound(2199-44-2), you can read my other articles.

Reference:
Thiazolidine – Wikipedia,
Thiazolidine – ScienceDirect.com